Patient group input submissions Ivabradine (Lancora) for heart failure, NYHA class II to IV

Patient group input submissions Ivabradine (Lancora) for heart failure, NYHA class II to IV

Detalles Bibliográficos
Autor principal: Canadian Agency for Drugs and Technologies in Health (author)
Autor Corporativo: Canadian Agency for Drugs and Technologies in Health, author, issuing body (author)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health 2017.
Materias:
Patient satisfaction.
Physician-Patient Relations.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820271806719

Ejemplares similares

Ejemplares similares